ACSL4 and posterior cortical atrophy: Finally, due to the critical role of ACSL4 expression in sensitizing tumors to ferroptosis inducers, it is intriguing to determine whether ACSL4 is epigenetically silenced in PCa and whether epigenetic inhibitors may be exploited for combination therapy with ferroptosis inducers to benefit a broader patient population.